Aperio Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$233K Sell
22,885
-4,084
-15% -$26.5K ﹤0.01% 2266
2020
Q3
$94K Buy
26,969
+5,597
+26% +$26.6K ﹤0.01% 2325
2020
Q2
$107K Buy
21,372
+3,582
+20% +$12.2K ﹤0.01% 2266
2020
Q1
$60K Buy
17,790
+7,379
+71% +$31.8K ﹤0.01% 2270
2019
Q4
$57K Sell
10,411
-1,314
-11% -$7.4K ﹤0.01% 2292
2019
Q3
$67K Sell
11,725
-550
-4% -$3.74K ﹤0.01% 2267
2019
Q2
$94K Buy
+12,275
New +$66.1K ﹤0.01% 2397
2018
Q4
Sell
-27,426
Closed -$472K 2324
2018
Q3
$472K Sell
27,426
-2,489
-8% -$37K ﹤0.01% 1795
2018
Q2
$417K Sell
29,915
-5,275
-15% -$89.1K ﹤0.01% 1833
2018
Q1
$539K Buy
35,190
+16,627
+90% +$238K ﹤0.01% 1663
2017
Q4
$214K Buy
+18,563
New +$276K ﹤0.01% 2122
2017
Q1
Sell
-8,899
Closed -$214K 2156
2016
Q4
$214K Buy
+8,899
New +$248K ﹤0.01% 1971
2016
Q2
Sell
-8,901
Closed -$299K 2026
2016
Q1
$299K Buy
+8,901
New +$280K ﹤0.01% 1658

Other funds holding PGEN

Aperio Group's PGEN Position: Q4 2020 in Review

Aperio Group reduced its Precigen (PGEN) stake by 15% in Q4 2020, selling an estimated $26.5K and leaving 22,885 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

Aperio Group first reported a position in PGEN in Q1 2016 and has held it in 13 quarters since. The position peaked at $539K in Q1 2018. 151 funds tracked by Wall St. Rank hold PGEN as of Q4 2020.

  • Aperio Group held 22,885 shares of Precigen worth $233K as of Q4 2020.
  • Aperio Group sold 4,084 Precigen shares in Q4 2020, an estimated $26.5K.
  • Precigen made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2266 holding.
  • Aperio Group first reported a position in Precigen in Q1 2016 and has held it in 13 quarters since.
  • Aperio Group's Precigen position peaked at $539K in Q1 2018.
  • 151 funds tracked by Wall St. Rank held Precigen as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.